LGL · Lgl Group Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-16 | GABELLI MARIO J |
10% Owner |
Exercise↓
|
Subscription Rights (right to purchase)
|
621,928 |
| 2026-07-16 | GABELLI MARIO J |
10% Owner |
Exercise↑
|
Common Stock
|
621,928 |
| 2026-07-16 | GABELLI MARIO J |
10% Owner |
Exercise↓
Filing footnotes — Subscription Rights (right to purchase) (Indirect)
These shares are owned by GGCP, Inc. ("GGCP"). Mr. Gabelli is deemed the beneficial owner of the shares owned by GGCP since he is the co-Chief Executive Officer, a director and a controlling shareholder of GGCP. Mr. Gabelli has less than a 100% interest in GGCP and disclaims beneficial ownership of the shares held by GGCP in excess of his pecuniary interest. |
Subscription Rights (right to purchase)
(I)
|
572,324 |
| 2026-07-16 | GABELLI MARIO J |
10% Owner |
Exercise↑
Filing footnotes — Common Stock (Indirect)
These shares are owned by GGCP, Inc. ("GGCP"). Mr. Gabelli is deemed the beneficial owner of the shares owned by GGCP since he is the co-Chief Executive Officer, a director and a controlling shareholder of GGCP. Mr. Gabelli has less than a 100% interest in GGCP and disclaims beneficial ownership of the shares held by GGCP in excess of his pecuniary interest. |
Common Stock
(I)
|
572,324 |
| 2026-07-15 | Lamb Jason D |
Chief Executive Officer |
Exercise↑
Filing footnotes — Subscription Rights (right to purchase) (Direct)
On June 8, 2026, holders of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), received one subscription right (the "Rights") for each share of Common Stock held by such holder as of June 4, 2026. When exercisable, one (1) Right entitled their holder to purchase one share of Common Stock at an exercise price of $6.90 per share. |
Subscription Rights (right to purchase)
|
50,000 |
| 2026-07-15 | Hayden Tiffany Renee |
Vice President |
Sell↓
Filing footnotes — Subscription Rights (right to purchase) (Direct)
On June 5, 2026, holders of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), received one transferable subscription right (the "Rights") for each share of Common Stock held by such holder as of June 4, 2026. When exercisable, one (1) Right will entitle their holder to purchase one (1) share of Common Stock at an exercise price of $6.90 per share. |
Subscription Rights (right to purchase)
|
10,000 |
| 2026-07-15 | Huvane Patrick |
Interim Co-CFO |
Exercise↑
Filing footnotes — Common Stock (Direct)
The shares shown in this line are the additional shares purchased pursuant to the Over-Subscription Privilege as part of the Rights Offering. |
Common Stock
|
1,000 |
| 2026-07-15 | GABELLI MARC |
Director |
Exercise↑
Filing footnotes — Common Stock (Indirect)
These shares are beneficially owned by Venator Merchant Fund, L.P. ("Venator Fund") and Venator Global LLC ("Venator Global"). Venator Global, which is the sole general partner of Venator Fund, is deemed to have beneficial ownership of the securities owned by Venator Fund. Marc Gabelli is the President of Venator Fund. |
Common Stock
(I)
|
1,477,660 |
| 2026-07-15 | Lamb Jason D |
Chief Executive Officer |
Exercise↑
|
Common Stock
|
50,000 |
| 2026-07-15 | Huvane Patrick |
Interim Co-CFO |
Exercise↑
Filing footnotes — Subscription Rights (right to purchase) (Direct)
On June 8, 2026, holders of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), received one subscription right (the "Rights") for each share of Common Stock held by such holder as of June 4, 2026. When exercisable, one (1) Right entitled their holder to purchase one share of Common Stock at an exercise price of $6.90 per share. |
Subscription Rights (right to purchase)
|
8,621 |
| 2026-07-15 | GABELLI MARC |
Director |
Exercise↑
|
Common Stock
|
1,854,015 |
| 2026-07-15 | GABELLI MARC |
Director |
Exercise↓
|
Subscription Rights (right to purchase)
|
114,523 |
| 2026-07-15 | GABELLI MARC |
Director |
Exercise↓
Filing footnotes — Subscription Rights (right to purchase) (Indirect)
These shares are beneficially owned by Venator Merchant Fund, L.P. ("Venator Fund") and Venator Global LLC ("Venator Global"). Venator Global, which is the sole general partner of Venator Fund, is deemed to have beneficial ownership of the securities owned by Venator Fund. Marc Gabelli is the President of Venator Fund. |
Subscription Rights (right to purchase)
(I)
|
764,303 |
| 2026-07-15 | Huvane Patrick |
Interim Co-CFO |
Exercise↑
Filing footnotes — Common Stock (Direct)
On June 8, 2026, holders of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), received one subscription right (the "Rights") for each share of Common Stock held by such holder as of June 4, 2026. When exercisable, one (1) Right entitled their holder to purchase one share of Common Stock at an exercise price of $6.90 per share. |
Common Stock
|
8,621 |
| 2026-06-15 | GABELLI MARIO J |
10% Owner |
Sell↓
|
Subscription Rights (right to purchase)
|
10,342 |
| 2026-03-26 | Francois Herve |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/26/2029. |
Common Stock
|
2,067 |
| 2026-03-26 | Kilrain Colin J. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/26/2029. |
Common Stock
|
2,067 |
| 2026-03-26 | GABELLI MARC |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/26/2029. |
Common Stock
|
2,067 |
| 2026-03-26 | Kalha Manjit |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/26/2029. |
Common Stock
|
2,067 |
| 2026-03-26 | Aslansan Kaan Kerem |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/26/2029. |
Common Stock
|
2,067 |
| 2026-03-26 | DeRemer Darlene T |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/26/2029. |
Common Stock
|
2,067 |
| 2026-01-21 | Huvane Patrick |
Interim Co-CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares were withheld by the issuer on January 21, 2026 to satisfy tax withholding obligations in connection with the vesting of 3,333 shares of restricted stock on January 16, 2026. |
Common Stock
|
1,379 |
| 2026-01-16 | Lamb Jason D |
Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
All options reported in this Form 4 are fully vested as of the date of grant. |
Stock Option (right to buy)
|
50,000 |
| 2026-01-16 | GABELLI MARC |
Director |
Convert↑
|
Common Stock
|
8,552 |
| 2026-01-16 | GABELLI MARC |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
One third of these shares vest immediately, one third of these shares vest in one year from the date of the grant, on 1/16/2027 and one third of these shares vest in two years from the date of the grant, on 1/16/2028. |
Common Stock
|
50,000 |
| 2026-01-16 | GABELLI MARIO J |
10% Owner |
Convert↑
|
Common Stock
|
169,993 |
| 2026-01-16 | GABELLI MARC |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
Sixty percent of these shares are exercisable immediately on the grant date, twenty percent on 1/16/2027 and twenty percent on 1/16/2028. |
Stock Options
|
100,000 |
| 2026-01-16 | GABELLI MARC |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
One hundred percent of these shares are exercisable immediately on the grant date. |
Stock Options
|
50,000 |
| 2026-01-16 | Huvane Patrick |
Interim Co-CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares, subject to vesting: 3,333 shares immediately; 3,333 shares on January 16, 2027; and 3,334 shares on January 16, 2028. |
Common Stock
|
10,000 |
| 2026-01-16 | Biles Linda M |
EVP Finance |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares, subject to vesting: 3,333 shares immediately; 3,333 shares on January 16, 2027; and 3,334 shares on January 16, 2028. |
Common Stock
|
10,000 |
| 2026-01-16 | Hayden Tiffany Renee |
Vice President |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares, subject to vesting: 3,333 shares immediately; 3,333 shares on January 16, 2027; and 3,334 shares on January 16, 2028 |
Common Stock
|
10,000 |
| 2026-01-16 | Lamb Jason D |
Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares, subject to vesting: 16,666 shares immediately; 16,666 shares on January 16, 2027; and 16,668 shares on January 16, 2028. |
Common Stock
|
50,000 |
| 2025-12-30 | GABELLI MARIO J |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
These shares are owned by GGCP, Inc. ("GGCP"). Mr. Gabelli is deemed the beneficial owner of the shares owned by GGCP since he is the Chief Executive Officer, a director and the controlling shareholder of GGCP. Mr. Gabelli has less than a 100% interest in GGCP and disclaims beneficial ownership of the shares held by GGCP in excess of his pecuniary interest. |
Common Stock
(I)
|
95,387 |
| 2025-03-25 | GABELLI MARC |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/25/2028. |
Common Stock
|
2,308 |
| 2025-03-25 | DeRemer Darlene T |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/25/2028. |
Common Stock
|
2,308 |
| 2025-03-25 | Kalha Manjit |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/25/2028. The original Form 4, filed on March 27, 2025, is being amended by this Form 4/A solely to correct an administrative error in Column 5 of Table I. The original filing inadvertently reported that the Reporting Person owned 29,993 shares following the transaction; however, as reported in this amendment, the Reporting Person actually owned 29,933 shares. This correction also addresses the incorrect balances reported in subsequent intervening filings. |
Common Stock
|
2,308 |
| 2025-03-25 | Foufas Timothy |
Co-President and Secretary |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/25/2028. |
Common Stock
|
2,308 |
| 2025-03-25 | Francois Herve |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/25/2028. |
Common Stock
|
2,308 |
| 2025-03-25 | Aslansan Kaan Kerem |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/25/2028. |
Common Stock
|
2,308 |
| 2025-03-25 | FERRANTINO MICHAEL J JR |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 3/25/2028. |
Common Stock
|
2,308 |
| 2023-12-08 | DeRemer Darlene T |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 12/8/2026. |
Common Stock
|
2,874 |
| 2023-12-08 | Kalha Manjit |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 12/8/2026. |
Common Stock
|
2,874 |
| 2023-12-08 | GABELLI MARC |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 12/8/2026. |
Common Stock
|
2,874 |
| 2023-12-08 | Foufas Timothy |
Co-President and Secretary |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 12/8/2026. |
Common Stock
|
2,874 |
| 2023-12-08 | Aslansan Kaan Kerem |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 12/8/2026. |
Common Stock
|
2,874 |
| 2023-12-08 | Francois Herve |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 12/8/2026. |
Common Stock
|
2,874 |
| 2023-12-08 | FERRANTINO MICHAEL J JR |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
These shares vest 3 years from the date of grant, on 12/8/2026. |
Common Stock
|
2,874 |
| 2022-10-07 | Tivy James William |
Chief Financial Officer |
Other↓
|
Common Stock
|
30,000 |
| 2022-10-07 | FERRANTINO MICHAEL J JR |
Director, Chief Executive Officer |
Other↓
|
Common Stock
|
15,000 |
| 2022-10-07 | Biles Linda M |
EVP Finance |
Other↓
|
Common Stock
|
7,533 |